Annals of Indian Academy of Neurology
  Users Online: 761 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
Year : 2010  |  Volume : 13  |  Issue : 1  |  Page : 6-13

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention

Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi, India

Correspondence Address:
Padma Srivastava
Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-2327.61270

Rights and Permissions

Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded407    
    Comments [Add]    
    Cited by others 7    

Recommend this journal